Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Cheng Chiang

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Molecular Oncology|January 24, 2012
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-responseYu-Li Chen, Ming-Cheng Chang, Chia-Yen Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 11, 2022
Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancerMing-Cheng Chang, Ping-Fang Chiang, Yu-Jen Kuo, et al.
Taiwanese Journal of Obstetrics & Gynecology|August 15, 2017
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort studyYing-Cheng Chiang, Yun-Yuan Chen, Shu-Feng Hsieh, et al.
International Journal of Molecular Sciences|July 29, 2025
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing TumorsMing-Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang, et al.
Gynecologic Oncology|February 24, 2026
Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classificationKuang-Yen Lee, Tzu-Hsin Tseng, Wen-Chun Chang, et al.
American Journal of Cancer Research|May 18, 2016
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphineMing-Cheng Chang, Yu-Li Chen, Ying-Cheng Chiang, et al.
Clinical Science (London, England : 1979)|January 24, 2012
Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effectsMing-Cheng Chang, Chien-Nan Lee, Yu-Li Chen, et al.
Endocrine-Related Cancer|August 20, 2018
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cellsHan-Wei Lin, Ying-Cheng Chiang, Nai-Yun Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 30, 2025
Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective studyKuang-Yen Lee, Ying-Cheng Chiang, Jiun-Yi Sheen, et al.
American Journal of Translational Research|March 11, 2015
Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomasChi-An Chen, Ying-Cheng Chiang, Ming-Cheng Chang, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Molecular Oncology|January 24, 2012
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-responseYu-Li Chen, Ming-Cheng Chang, Chia-Yen Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 11, 2022
Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancerMing-Cheng Chang, Ping-Fang Chiang, Yu-Jen Kuo, et al.
Taiwanese Journal of Obstetrics & Gynecology|August 15, 2017
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort studyYing-Cheng Chiang, Yun-Yuan Chen, Shu-Feng Hsieh, et al.
International Journal of Molecular Sciences|July 29, 2025
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing TumorsMing-Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang, et al.
Gynecologic Oncology|February 24, 2026
Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classificationKuang-Yen Lee, Tzu-Hsin Tseng, Wen-Chun Chang, et al.
American Journal of Cancer Research|May 18, 2016
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphineMing-Cheng Chang, Yu-Li Chen, Ying-Cheng Chiang, et al.
Clinical Science (London, England : 1979)|January 24, 2012
Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effectsMing-Cheng Chang, Chien-Nan Lee, Yu-Li Chen, et al.
Endocrine-Related Cancer|August 20, 2018
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cellsHan-Wei Lin, Ying-Cheng Chiang, Nai-Yun Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 30, 2025
Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective studyKuang-Yen Lee, Ying-Cheng Chiang, Jiun-Yi Sheen, et al.
American Journal of Translational Research|March 11, 2015
Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomasChi-An Chen, Ying-Cheng Chiang, Ming-Cheng Chang, et al.
Pageof 8